SEC Company Response from TuHURA Biosciences, (HURA) — Jul 2, 2015

TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)
Date: July 2, 2015 · CIK: 0001498382 · Accession: 0001013762-15-000680

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-203357

Referenced dates: July 1, 2015

Date

July 1, 2015

Author

Jeffrey Bacha

Form

CORRESP

Company

TuHURA Biosciences, Inc./NV (HURA) (CIK 0001498382)

Letter

DelMar Pharmaceuticals, Inc.

Suite 720-999 West Broadway

Vancouver, British Columbia

Canada V5Z 1K5

July 2,

EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re: DelMar Pharmaceuticals, Inc.

Registration Statement on Form S-1

File No. 333-203357

Ladies and Gentlemen:

DelMar Pharmaceuticals, Inc. hereby requests withdrawal of its request for the acceleration of effectiveness of the above-referenced registration statement as set forth in its letter dated July 1, 2015.

DelMar Pharmaceuticals, Inc.

By: /s/Jeffrey Bacha

Name: Jeffrey Bacha Title: Chief Executive Officer

Show Raw Text

CORRESP
1
filename1.htm

DelMar Pharmaceuticals, Inc.

Suite 720-999 West Broadway

Vancouver, British Columbia

Canada V5Z 1K5

July 2,
2015

EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

Re:  DelMar Pharmaceuticals, Inc.

    Registration Statement on Form S-1

    File No. 333-203357

Ladies
and Gentlemen:

DelMar
Pharmaceuticals, Inc. hereby requests withdrawal of its request for the acceleration of effectiveness of the above-referenced registration
statement as set forth in its letter dated July 1, 2015.

    DelMar Pharmaceuticals, Inc.

    By:
    /s/Jeffrey Bacha

    Name: Jeffrey Bacha
Title: Chief Executive Officer

SecProbe.io